Singapore's Raffles Medical H1 revenue falls 6.7%, profit down 9.8%

Raffles Medical

27/07/2026 01:19

Overview
Singapore healthcare provider's H1 2026 revenue fell 6.7% yr/yr to S$353.2 mln
Net profit after tax declined 9.8% yr/yr to S$29.3 mln
Lower occupancy at transitional care facilities weighed on healthcare services division's revenue and profit

Outlook
Company expects to remain profitable for FY2026 barring unforeseen circumstances
Company sees demand for healthcare services expected to remain resilient despite economic uncertainty
Raffles Medical Group to focus on integrated healthcare, regional expansion, and digital transformation

Result Drivers
LOWER OCCUPANCY - Co said Healthcare Services Division revenue fell 16% yr/yr due to lower occupancy at transitional care facilities
OPERATIONAL EFFICIENCY - Hospital Services Division profit rose 11% yr/yr, driven by improved operational efficiency and cost management
CHINA REVENUE GROWTH - RafflesChinaHealthcare revenue rose 13% yr/yr, supported by cost optimisation initiatives

Company press release: ID:nSN4pQWrD

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
H1 Revenue
 
S$353.20 mln
 
H1 Net Income
 
S$29.30 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Raffles Medical Group Ltd is S$1.25, about 31.6% above its July 24 closing price of S$0.95
The stock recently traded at 23 times the next 12-month earnings vs. a P/E of 24 three months ago

Reuters Recommended Reads
July 24 - HCA Healthcare Q2 revenue rises on Medicaid programs; narrows outlook
July 24 - India's Manipal Health to spend $414.4 million to expand capacity 
July 24 - Spain's Almirall H1 net sales rise, reiterates 2026 guidance 

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)